Trademark Overview
On Thursday, October 5, 2023, a trademark application was filed for TEPYLUTE with the United States Patent and Trademark Office. The USPTO has given the TEPYLUTE trademark a serial number of 98211517. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Sunday, May 12, 2024. This trademark is owned by Shorla Pharma Limited. The TEPYLUTE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical and medicinal drugs, products, preparations and substances; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical preparations, products and substances for human use; pharmaceutical preparations, products and substances for the prevention and treatment of cancer; compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations, products and substances for the prevention of tumours; anti-cancer drugs and preparations
Research and development services; biological research; scientific research services; research and development services in the pharmaceutical and biotechnology fields; research services relating to the development and testing of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation; testing and inspection of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; product safety and quality testing in the pharmaceutical and biotechnology fields; provision of information and data relating to research and development in the pharmaceutical and biotechnology fields